Explore insights and strategies for managing ATTR-CM long-term.
-
-
Tafamidis reduced amyloid in ATTR-CM but showed no symptom improvement
-
Single dose of ATTR therapy nucresiran reduced TTR levels, company says
-
FDA approves acoramidis to treat ATTR-CM
-
Sodium-glucose cotransporter-2 inhibitors could be useful for people with ATTR-CM
-
How ATTR-CM affects the heart: Understanding the cardiac element
-
Understanding hereditary versus nonhereditary ATTR-CM